发明名称 |
TRANSDERMAL ABSORPTION PREPARATION |
摘要 |
(Object) A transdermal preparation is provided, which ensures stable and effective absorption of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide (KRP-197) which has a low skin absorption and is a bladder-selective muscarinic M3 and M1 receptor antagonist, into body through the skin while causing little side effects and providing sustained pharmacological effect with less skin irritancy. (Solving means) A composition comprising KRP-197 and an external preparation base is deposited and dried onto a structural body or a small pool of the composition is deposited on the structural body to obtain a single adhesive layer-type transdermal preparation or a reservoir-type transdermal preparation. These preparations can ensure high permeation of KRP-197 through the skin and sustained absorption of KRP-197 into body while causing decreased skin irritancy.
|
申请公布号 |
EP1652523(A1) |
申请公布日期 |
2006.05.03 |
申请号 |
EP20040748201 |
申请日期 |
2004.08.03 |
申请人 |
KYORIN PHARMACEUTICAL CO., LTD.;ONO PHARMACEUTICAL CO., LTD. |
发明人 |
NAKASHIMA, KATASHI;OHMORI, SATOSHI;KANAYAMA, NORIHIRO;SAKAI, YOSHIKI, |
分类号 |
A61K9/70;A61K31/4174;A61K47/06;A61K47/10;A61K47/12;A61K47/14;A61K47/30;A61K47/44;A61P13/10;C07D233/61;(IPC1-7):A61K31/417 |
主分类号 |
A61K9/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|